Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOFOGLIFLOZIN: 54 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
54
Total FAERS Reports
7 (13.0%)
Deaths Reported
32
Hospitalizations
54
As Primary/Secondary Suspect
5
Life-Threatening

First Report: 20140604 · Latest Report: 20240901

What Are the Most Common TOFOGLIFLOZIN Side Effects?

#1 Most Reported
Hyperglycaemia
10 reports (18.5%)
#2 Most Reported
Diabetic ketoacidosis
6 reports (11.1%)
#3 Most Reported
Vomiting
5 reports (9.3%)

All TOFOGLIFLOZIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hyperglycaemia 10 18.5% 4 7
Diabetic ketoacidosis 6 11.1% 0 4
Vomiting 5 9.3% 1 3

Who Reports TOFOGLIFLOZIN Side Effects? Age & Gender Data

Gender: 50.0% female, 50.0% male. Average age: 66.2 years. Most reports from: JP. View detailed demographics →

Is TOFOGLIFLOZIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 8 3 4
2015 6 1 2
2016 3 0 2
2017 3 0 3
2018 5 0 2
2019 4 1 4
2020 2 0 2
2021 2 2 0
2022 1 0 1
2023 2 0 2
2024 2 0 1

View full timeline →

What Is TOFOGLIFLOZIN Used For?

IndicationReports
Type 2 diabetes mellitus 26
Diabetes mellitus 14
Product used for unknown indication 7

Official FDA Label for TOFOGLIFLOZIN

Official prescribing information from the FDA-approved drug label.